Penumbra Gross Profit 2014-2024 | PEN

Penumbra annual/quarterly gross profit history and growth rate from 2014 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Penumbra gross profit for the quarter ending March 31, 2024 was $0.181B, a 19.9% increase year-over-year.
  • Penumbra gross profit for the twelve months ending March 31, 2024 was $0.713B, a 27.53% increase year-over-year.
  • Penumbra annual gross profit for 2023 was $0.683B, a 27.55% increase from 2022.
  • Penumbra annual gross profit for 2022 was $0.535B, a 12.58% increase from 2021.
  • Penumbra annual gross profit for 2021 was $0.475B, a 40.57% increase from 2020.
Penumbra Annual Gross Profit
(Millions of US $)
2023 $683
2022 $535
2021 $475
2020 $338
2019 $372
2018 $293
2017 $217
2016 $171
2015 $124
2014 $83
2013 $58
Penumbra Quarterly Gross Profit
(Millions of US $)
2024-03-31 $181
2023-12-31 $187
2023-09-30 $178
2023-06-30 $167
2023-03-31 $151
2022-12-31 $138
2022-09-30 $135
2022-06-30 $134
2022-03-31 $127
2021-12-31 $125
2021-09-30 $120
2021-06-30 $119
2021-03-31 $111
2020-12-31 $94
2020-09-30 $91
2020-06-30 $65
2020-03-31 $88
2019-12-31 $98
2019-09-30 $96
2019-06-30 $94
2019-03-31 $84
2018-12-31 $79
2018-09-30 $75
2018-06-30 $72
2018-03-31 $67
2017-12-31 $64
2017-09-30 $55
2017-06-30 $51
2017-03-31 $48
2016-12-31 $47
2016-09-30 $43
2016-06-30 $41
2016-03-31 $40
2015-12-31 $36
2015-09-30 $33
2015-06-30 $27
2015-03-31 $27
2014-12-31
2014-09-30 $21
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.261B $1.059B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.815B 26.27
Intuitive Surgical (ISRG) United States $152.521B 91.88
Edwards Lifesciences (EW) United States $52.348B 34.07
DexCom (DXCM) United States $46.342B 70.20
Alcon (ALC) Switzerland $43.615B 31.25
IDEXX Laboratories (IDXX) United States $41.651B 48.82
IQVIA Holdings (IQV) United States $38.867B 22.55
STERIS (STE) Ireland $21.364B 24.96
SONOVA HOLDING (SONVY) Switzerland $18.279B 0.00
Waters (WAT) United States $17.455B 25.65
Hologic (HOLX) United States $16.670B 18.65
Fresenius Medical Care AG KGaA (FMS) Germany $11.719B 13.68
Sysmex ADR (SSMXY) Japan $10.095B 31.66
Teleflex (TFX) United States $9.692B 15.09
Globus Medical (GMED) United States $9.027B 26.46
Masimo (MASI) United States $7.185B 41.39
Glaukos (GKOS) United States $5.641B 0.00
TransMedics (TMDX) United States $4.713B 447.11
Integer Holdings (ITGR) United States $3.930B 23.75
PROCEPT BioRobotics (PRCT) United States $3.190B 0.00
LivaNova (LIVN) United Kingdom $2.867B 17.03
Tandem Diabetes Care (TNDM) United States $2.777B 0.00
Nihon Kohden (NHNKY) Japan $2.650B 14.04
Inari Medical (NARI) United States $2.513B 0.00
Elekta AB (EKTAY) Sweden $2.397B 18.38
Integra LifeSciences Holdings (IART) United States $2.277B 9.93
RxSight (RXST) United States $2.075B 0.00
Veracyte (VCYT) United States $1.634B 0.00
Alphatec Holdings (ATEC) United States $1.466B 0.00
Artivion (AORT) United States $0.966B 92.68
OPKO Health (OPK) United States $0.871B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.869B 16.91
Silk Road Medical (SILK) United States $0.855B 0.00
OrthoPediatrics (KIDS) United States $0.701B 0.00
Pulse Biosciences (PLSE) United States $0.654B 0.00
IRadimed (IRMD) United States $0.545B 30.52
SiBone (SIBN) United States $0.515B 0.00
Paragon 28 (FNA) United States $0.503B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.67
ORTHOFIX MEDICAL INC (OFIX) United States $0.472B 0.00
Pacific Biosciences Of California (PACB) United States $0.455B 0.00
Treace Medical Concepts (TMCI) United States $0.377B 0.00
Nevro (NVRO) United States $0.328B 0.00
AxoGen (AXGN) United States $0.324B 0.00
Sight Sciences (SGHT) United States $0.321B 0.00
Tactile Systems Technology (TCMD) United States $0.279B 9.54
Semler Scientific (SMLR) United States $0.273B 13.85
CVRx (CVRX) United States $0.237B 0.00
AngioDynamics (ANGO) United States $0.236B 0.00
Delcath Systems (DCTH) United States $0.215B 0.00
EDAP TMS S.A (EDAP) France $0.198B 0.00
908 Devices (MASS) United States $0.196B 0.00
NeuroPace (NPCE) United States $0.187B 0.00
Accuray (ARAY) United States $0.186B 0.00
Inogen (INGN) United States $0.171B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Atossa Genetics (ATOS) United States $0.145B 0.00
Yubo Biotech (YBGJ) China $0.128B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.086B 18.00
EnVVeno Medical (NVNO) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.062B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
Neuronetics (STIM) United States $0.057B 0.00
SEP Acquisition (SEPA) United States $0.057B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.048B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
ReWalk Robotics (LFWD) Israel $0.038B 0.00
Lucid Diagnostics (LUCD) United States $0.037B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Vicarious Surgical (RBOT) United States $0.034B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.022B 0.00
Aspira Women's Health (AWH) United States $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00